𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Participation in disease management of a health insurance company: characteristics and assessment of the process and outcome parameters in the programme

✍ Scribed by P. Javaher; G. Seidel; M. ‐L. Dierks

Publisher
Springer
Year
2005
Tongue
English
Weight
350 KB
Volume
14
Category
Article
ISSN
1741-3842

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outcome assessment in clinical trials ev
Outcome assessment in clinical trials evidence for the sensitivity of a health status measure
✍ Robert F. Meenan; Jennifer J. Anderson; Lewis E. Kazis; Marlene J. Egger; Mary A 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 828 KB

Health status measures are conceptually relevant to the assessment of clinical outcome in the rheumatic diseases, but their ability to detect meaningful changes in health has not been clearly demonstrated. This report describes the performance of a self-administered health status questionnaire in a

Assessment of health economics in Alzhei
Assessment of health economics in Alzheimer's disease (AHEAD): treatment with galantamine in the UK
✍ A. Ward; J. J. Caro; D. Getsios; K. Ishak; J. O'Brien; R. Bullock 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 2 views

## Abstract ## Objective To assess the long‐term health and economic impact of treating mild to moderate Alzheimer's disease (AD) with galantamine (16 mg or 24 mg per day) compared to no cholinesterase therapy in the UK. ## Methods The long‐term costs and outcomes were assessed using a model dev